|
|
HLB Panagene Inc
KRX •
Healthcare •
Biotechnology •
Quote as of 10/30/2026
Company Profile
IndustryBiotechnology
SectorHealthcare
ExchangeKRX
Market Capitalization58,549 mln
Float30.79 mln
Relative Strength
24
/ 100
Significantly lagging
Key Fundamentals
EPS-72.14
ROE-4.48
ROIC-5.24
ROA-3.51
EBITDA, mln-805
EV / EBITDA-49.37
EV / EBIT-15.80
Revenue, mln14,708
EV / Revenue2.70
Quote Details
Last
1,259.00
Change
-6 (-0.47%)
Open
1,231.00
Volume
108,458
Turnover
136,548,624
Average Volume
1,010,823
Financial Ratios
Pre-Tax Profit Margin-22
Current Ratio4.94
Price / Book0.79
Price / Tangible Book0.83
Debt / Equity0.08
Price / Sales3.93
Financial Strength
Altman Z-Score4.77
Piotroski F-Score
4
/ 9
Beneish M-Score-2.06
Price to Intrinsic Value0.84
Price Performance & Relative Strength
| Period |
Price Performance |
Relative Strength |
| 1 Week |
-9.62% |
9
/ 100
 |
| 1 Month |
-2.02% |
75
/ 100
 |
| 2 Months |
18.33% |
90
/ 100
 |
| 6 Months |
-42.38% |
25
/ 100
 |
| 1 Year |
-22.95% |
39
/ 100
 |
|
| |
